Michel MC - Search Results

1

Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders.

Michel MC, Cardozo L, Chermansky CJ, Cruz F, Igawa Y, Lee KS, Sahai A, Wein AJ, Andersson KE. Michel MC, et al. Pharmacol Rev. 2023 Jul;75(4):554-674. doi: 10.1124/pharmrev.121.000523. Epub 2023 Mar 14. Pharmacol Rev. 2023. PMID: 36918261 Review.

2

Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence.

Andersson KE, Chapple CR, Cardozo L, Cruz F, Hashim H, Michel MC, Tannenbaum C, Wein AJ. Andersson KE, et al. Among authors: michel mc. Curr Opin Urol. 2009 Jul;19(4):380-94. doi: 10.1097/MOU.0b013e32832ce8a4. Curr Opin Urol. 2009. PMID: 19448545 Review.

3

β-adrenoceptor agonist effects in experimental models of bladder dysfunction.

Michel MC, Ochodnicky P, Homma Y, Igawa Y. Michel MC, et al. Pharmacol Ther. 2011 Jul;131(1):40-9. doi: 10.1016/j.pharmthera.2011.03.014. Epub 2011 Apr 12. Pharmacol Ther. 2011. PMID: 21510978 Review.

4

Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322.

Igawa Y, Schneider T, Yamazaki Y, Tatemichi S, Homma Y, Nishizawa O, Michel MC. Igawa Y, et al. Among authors: michel mc. Naunyn Schmiedebergs Arch Pharmacol. 2012 Aug;385(8):759-67. doi: 10.1007/s00210-012-0763-x. Epub 2012 May 29. Naunyn Schmiedebergs Arch Pharmacol. 2012. PMID: 22644105

5

Pharmacological profile of β3-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome.

Igawa Y, Michel MC. Igawa Y, et al. Among authors: michel mc. Naunyn Schmiedebergs Arch Pharmacol. 2013 Mar;386(3):177-83. doi: 10.1007/s00210-012-0824-1. Epub 2012 Dec 21. Naunyn Schmiedebergs Arch Pharmacol. 2013. PMID: 23263450

6

Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability.

Chapple CR, Cardozo L, Nitti VW, Siddiqui E, Michel MC. Chapple CR, et al. Among authors: michel mc. Neurourol Urodyn. 2014 Jan;33(1):17-30. doi: 10.1002/nau.22505. Epub 2013 Oct 11. Neurourol Urodyn. 2014. PMID: 24127366 Review.

7

Therapeutic targets for overactive bladder other than smooth muscle.

Michel MC, Igawa Y. Michel MC, et al. Expert Opin Ther Targets. 2015 May;19(5):687-705. doi: 10.1517/14728222.2015.1009447. Epub 2015 Feb 23. Expert Opin Ther Targets. 2015. PMID: 25704500 Review.

8

β₃ -Adrenoceptors in the normal and diseased urinary bladder-What are the open questions?

Igawa Y, Aizawa N, Michel MC. Igawa Y, et al. Among authors: michel mc. Br J Pharmacol. 2019 Jul;176(14):2525-2538. doi: 10.1111/bph.14658. Epub 2019 May 3. Br J Pharmacol. 2019. PMID: 30868554 Free PMC article. Review.

9

A 25-Year Journey as Author and Associate Editor of Pharmacological Reviews-Editorial.

Michel MC. Michel MC. Pharmacol Rev. 2024 Feb 13;76(2):196-198. doi: 10.1124/pharmrev.123.000990. Pharmacol Rev. 2024. PMID: 38351073 No abstract available.

10

Pharmacogenomics of G protein-coupled receptor ligands in cardiovascular medicine.

Rosskopf D, Michel MC. Rosskopf D, et al. Among authors: michel mc. Pharmacol Rev. 2008 Dec;60(4):513-35. doi: 10.1124/pr.108.000612. Epub 2008 Dec 12. Pharmacol Rev. 2008. PMID: 19074621 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

640 results

Search Page

Filters